Loading...
ROCO
6523
Market cap127mUSD
Jul 09, Last price  
91.00TWD
1D
0.44%
1Q
-21.55%
Jan 2017
-49.30%
IPO
-53.73%
Name

DR.Wu Skincare Co Ltd

Chart & Performance

D1W1MN
ROCO:6523 chart
P/E
11.70
P/S
3.51
EPS
7.78
Div Yield, %
10.99%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
8.85%
Revenues
1.17b
-5.92%
565,499,000662,809,000865,214,0001,150,595,000936,922,000962,998,0001,014,212,000764,630,0001,106,011,000926,791,0001,137,145,0001,241,755,0001,168,262,000
Net income
350m
-26.45%
188,679,000239,244,000228,390,000312,123,000127,255,00024,839,000191,797,000661,110,000296,242,000339,981,000424,733,000476,253,000350,273,000
CFO
341m
-22.02%
157,782,000176,220,000166,449,000281,054,00093,828,000120,671,000223,552,000300,908,000289,603,000325,829,000392,440,000437,181,000340,924,000
Dividend
Dec 04, 20254 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dr. Wu Skincare Co., Ltd. is a company that develops and distributes a broad spectrum of skincare and cosmetic products, serving both the Taiwanese domestic market and an international clientele. Their comprehensive product range includes facial cleansers, treatment masks, toners, concentrated serums, various moisturizers (lotions, creams, and gels), UV/DD creams for sun protection, and specialized eye care, alongside general makeup and body care items. Furthermore, the company formulates targeted solutions for specific skin concerns such as acne and pore issues, blackheads, dry skin conditions, visible signs of aging, dull or spotty complexions, sensitive skin, brightening, and emergency skin care. These products are made available through an extensive retail network comprising approximately 2,000 sales locations in diverse regions including Mainland China, Myanmar, Thailand, Malaysia, Singapore, Canada, Vietnam, the Philippines, and Japan. Founded in 2003, Dr. Wu Skincare Co., Ltd. is headquartered in Taipei, Taiwan.
IPO date
Apr 30, 2015
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT